These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 11719448)

  • 61. [Neutron capture therapy for cancer].
    Fukuda H; Ichihashi M; Mishima Y
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):374-8. PubMed ID: 8109994
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
    Morita N; Hiratsuka J; Kondoh H; Uno M; Asano T; Niki Y; Sakurai Y; Ono K; Harada T; Imajo Y
    Cancer Res; 2006 Apr; 66(7):3747-53. PubMed ID: 16585201
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption.
    Yang W; Barth RF; Carpenter DE; Moeschberger ML; Goodman JH
    Neurosurgery; 1996 May; 38(5):985-92. PubMed ID: 8727825
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
    Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG
    Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy.
    Coderre JA; Glass JD; Fairchild RG; Roy U; Cohen S; Fand I
    Cancer Res; 1987 Dec; 47(23):6377-83. PubMed ID: 3677082
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentina.
    Liberman SJ; Dagrosa A; Jiménez Rebagliati RA; Bonomi MR; Roth BM; Turjanski L; Castiglia SI; González SJ; Menéndez PR; Cabrini R; Roberti MJ; Batistoni DA
    Appl Radiat Isot; 2004 Nov; 61(5):1095-100. PubMed ID: 15308198
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP.
    Viaggi M; Dagrosa MA; Longhino J; Blaumann H; Calzetta O; Kahl SB; Juvenal GJ; Pisarev MA
    Appl Radiat Isot; 2004 Nov; 61(5):905-9. PubMed ID: 15308166
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Subcellular distribution of various boron compounds and implications for their efficacy in boron neutron capture therapy by Monte Carlo simulations.
    Nguyen T; Brownell GL; Holden SA; Kahl S; Miura M; Teicher BA
    Radiat Res; 1993 Jan; 133(1):33-40. PubMed ID: 8434111
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Imaging of fluorine and boron from fluorinated boronophenylalanine in the same cell at organelle resolution by correlative ion microscopy and confocal laser scanning microscopy.
    Chandra S; Kabalka GW; Lorey DR; Smith DR; Coderre JA
    Clin Cancer Res; 2002 Aug; 8(8):2675-83. PubMed ID: 12171900
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
    Bergenheim AT; Capala J; Roslin M; Henriksson R
    J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biodistribution of boron in dogs with spontaneous intracranial tumors following borocaptate sodium administration.
    Kraft SL; Gavin PR; Leathers CW; DeHaan CE; Bauer WF; Miller DL; Dorn RV; Griebenow ML
    Cancer Res; 1994 Mar; 54(5):1259-63. PubMed ID: 8118814
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model.
    Heber EM; Trivillin VA; Nigg DW; Itoiz ME; Gonzalez BN; Rebagliati RJ; Batistoni D; Kreimann EL; Schwint AE
    Arch Oral Biol; 2006 Oct; 51(10):922-9. PubMed ID: 16696934
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy.
    Capuani S; Porcari P; Fasano F; Campanella R; Maraviglia B
    Magn Reson Imaging; 2008 Sep; 26(7):987-93. PubMed ID: 18486394
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Analysis of 10B antitumoral compounds by means of flow-injection into ESI-MS/MS.
    Basilico F; Sauerwein W; Pozzi F; Wittig A; Moss R; Mauri PL
    J Mass Spectrom; 2005 Dec; 40(12):1546-9. PubMed ID: 16320299
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases.
    Cardoso JE; Trivillin VA; Heber EM; Nigg DW; Calzetta O; Blaumann H; Longhino J; Itoiz ME; Bumaschny E; Pozzi E; Schwint AE
    Int J Radiat Biol; 2007 Oct; 83(10):699-706. PubMed ID: 17729164
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Radiobiology of BNCT mediated by GB-10 and GB-10+BPA in experimental oral cancer.
    Trivillin VA; Heber EM; Itoiz ME; Nigg D; Calzetta O; Blaumann H; Longhino J; Schwint AE
    Appl Radiat Isot; 2004 Nov; 61(5):939-45. PubMed ID: 15308172
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
    Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
    Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Biodistribution of p-borophenylalanine (BPA) in dogs with spontaneous undifferentiated thyroid carcinoma (UTC).
    Dagrosa MA; Viaggi M; Rebagliati RJ; Castillo VA; Batistoni D; Cabrini RL; Castiglia S; Juvenal GJ; Pisarev MA
    Appl Radiat Isot; 2004 Nov; 61(5):911-5. PubMed ID: 15308167
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].
    Pisarev MA; Dagrosa MA; Thomasz L; Juvenal G
    Medicina (B Aires); 2006; 66(6):569-73. PubMed ID: 17240633
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine.
    Packer S; Coderre J; Saraf S; Fairchild R; Hansrote J; Perry H
    Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):395-403. PubMed ID: 1740371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.